Xeris Biopharma Holdings Inc
XERS
Market Cap$632.69M
Close$
$2.89
28.1% downside
Current Fair Value
28.1% downsideOvervalued by 28.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $632.69 Million |
|---|---|
| Enterprise Value | $615.51 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.37 |
| Beta | 0.89 |
| Outstanding Shares | 149,092,881 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.17 |
|---|---|
| PEG | -38.38 |
| Price to Sales | 4.02 |
| Price to Book Ratio | -4.02 |
| Enterprise Value to Revenue | 3.31 |
| Enterprise Value to EBIT | -13.63 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | -1.84 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Xeris Pharmaceuticals Inc
CEO: paul Edick